Neurofibromatosis refers to three genetic disorders (neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis) that cause tumors to form on nerve tissue. The tumors are typically benign, but can become malignant. Neurofibromatosis can cause hearing loss, learning impairments, heart and blood vessel complications, vision loss and severe pain. Cannabis is a potential treatment option for neurofibromatosis not only because it has anti-tumor properties, but also because it can help manage the pain associated with the condition.
In one study, two children with neurofibromatosis 1 witnessed their tumors regress within three years through the use of inhaled cannabis. Both CBD and THC inhibit tumors, but CBD is more potent when it comes to inhibiting tumor cell viability, invasion, and their spread and growth. Additionally, cannabis has the ability to manage pain, even when the pain is generally resistant to conventional medications.
This information has been adapted from Medical Marijuana Inc. and approved by our Chief Medical Officer.